Net Debt Summary of Jinhe Biotechnology CO., LTD.

Jinhe Biotechnology CO., LTD.'s latest annual net debt in 2023 was 1.69 Billion CNY , up 52.36% from previous year.
Jinhe Biotechnology CO., LTD.'s latest quarterly net debt in 2024 Q3 was 1.3 Billion CNY , down -29.16% from previous quarter.
Jinhe Biotechnology CO., LTD. reported annual net debt of 1.11 Billion CNY in 2022, up 126.4% from previous year.
Jinhe Biotechnology CO., LTD. reported annual net debt of 490.43 Million CNY in 2021, down -51.85% from previous year.
Jinhe Biotechnology CO., LTD. reported quarterly net debt of 1.87 Billion CNY for 2024 Q2, up 5.46% from previous quarter.
Jinhe Biotechnology CO., LTD. reported quarterly net debt of 1.77 Billion CNY for 2024 Q1, up 5.22% from previous quarter.

Annual Net Debt Chart of Jinhe Biotechnology CO., LTD. (2023 - 2008)

Historical Annual Net Debt of Jinhe Biotechnology CO., LTD. (2023 - 2008)

Year	Net Debt	Net Debt Growth
2023	1.69 Billion CNY	52.36%
2022	1.11 Billion CNY	126.4%
2021	490.43 Million CNY	-51.85%
2020	1.01 Billion CNY	22.11%
2019	834.19 Million CNY	19.12%
2018	700.32 Million CNY	28.32%
2017	545.76 Million CNY	91.91%
2016	284.38 Million CNY	-27.66%
2015	393.13 Million CNY	108.71%
2014	188.36 Million CNY	176.81%
2013	-245.21 Million CNY	21.77%
2012	-313.45 Million CNY	-286.97%
2011	167.65 Million CNY	-23.32%
2010	218.64 Million CNY	5.9%
2009	206.46 Million CNY	11.84%
2008	184.6 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2024 Q3	1.3 Billion CNY	-29.16%
2024 Q2	1.87 Billion CNY	5.46%
2024 Q1	1.77 Billion CNY	5.22%
2023 Q3	1.61 Billion CNY	16.92%
2023 Q4	1.69 Billion CNY	4.65%
2023 FY	1.69 Billion CNY	52.36%
2023 Q1	1.27 Billion CNY	14.63%
2023 Q2	1.38 Billion CNY	8.63%
2022 Q2	611.61 Million CNY	21.72%
2022 Q3	755.36 Million CNY	23.5%
2022 Q4	1.11 Billion CNY	46.99%
2022 FY	1.11 Billion CNY	126.4%
2022 Q1	502.48 Million CNY	2.46%
2021 Q1	1.12 Billion CNY	10.64%
2021 Q2	1.16 Billion CNY	3.12%
2021 Q3	407.33 Million CNY	-64.95%
2021 Q4	490.43 Million CNY	20.4%
2021 FY	490.43 Million CNY	-51.85%
2020 Q3	1.02 Billion CNY	5.09%
2020 Q2	974.45 Million CNY	10.76%
2020 Q1	879.8 Million CNY	5.47%
2020 FY	1.01 Billion CNY	22.11%
2020 Q4	1.01 Billion CNY	-0.53%
2019 Q2	850.41 Million CNY	15.01%
2019 FY	834.19 Million CNY	19.12%
2019 Q4	834.19 Million CNY	1.11%
2019 Q1	739.45 Million CNY	5.59%
2019 Q3	825 Million CNY	-2.99%
2018 FY	700.32 Million CNY	28.32%
2018 Q4	700.32 Million CNY	-1.62%
2018 Q3	711.86 Million CNY	12.2%
2018 Q2	634.43 Million CNY	4.81%
2018 Q1	605.32 Million CNY	10.91%
2017 Q4	545.76 Million CNY	0.84%
2017 Q1	360.37 Million CNY	26.72%
2017 FY	545.76 Million CNY	91.91%
2017 Q2	532.07 Million CNY	47.64%
2017 Q3	541.23 Million CNY	1.72%
2016 FY	284.38 Million CNY	-27.66%
2016 Q4	284.38 Million CNY	68.26%
2016 Q3	169.01 Million CNY	-35.88%
2016 Q2	263.6 Million CNY	3953.47%
2016 Q1	6.5 Million CNY	-98.35%
2015 Q1	221.87 Million CNY	17.79%
2015 Q4	393.13 Million CNY	-4.36%
2015 Q3	411.04 Million CNY	43.0%
2015 Q2	287.43 Million CNY	29.55%
2015 FY	393.13 Million CNY	108.71%
2014 Q4	188.36 Million CNY	231.37%
2014 Q3	-143.38 Million CNY	-5.19%
2014 Q2	-136.31 Million CNY	28.7%
2014 Q1	-191.19 Million CNY	22.03%
2014 FY	188.36 Million CNY	176.81%
2013 Q2	-281.2 Million CNY	15.26%
2013 Q3	-245.12 Million CNY	12.83%
2013 Q4	-245.21 Million CNY	-0.04%
2013 Q1	-331.83 Million CNY	-5.86%
2013 FY	-245.21 Million CNY	21.77%
2012 Q4	-313.45 Million CNY	-0.95%
2012 Q2	176.05 Million CNY	0.0%
2012 FY	-313.45 Million CNY	-286.97%
2012 Q3	-310.5 Million CNY	-276.37%
2011 Q4	167.65 Million CNY	0.0%
2011 FY	167.65 Million CNY	-23.32%
2011 Q2	202.55 Million CNY	0.0%
2010 FY	218.64 Million CNY	5.9%
2009 FY	206.46 Million CNY	11.84%
2008 FY	184.6 Million CNY	0.0%

Peer Net Debt Comparison of Jinhe Biotechnology CO., LTD.

Name	Net Debt	Net Debt Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	7.91 Billion CNY	78.634%
Anhui Fengyuan Pharmaceutical Co., Ltd.	367.85 Million CNY	-359.875%
Dong-E-E-Jiao Co.,Ltd.	-5.77 Billion CNY	129.297%
Livzon Pharmaceutical Group Inc.	-6.28 Billion CNY	126.896%
Hainan Haiyao Co., Ltd.	2.99 Billion CNY	43.532%
Tus-Pharmaceutical Group Co., Ltd.	-56.07 Million CNY	3116.792%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.31 Billion CNY	-28.933%
Changchun High-Tech Industries (Group) Inc.	-5.87 Billion CNY	128.789%
Apeloa Pharmaceutical Co.,Ltd	-154.02 Million CNY	1198.313%
PKU HealthCare Corp.,Ltd.	-375.11 Million CNY	550.978%
Chengdu Huasun Technology Group Inc., Ltd.	204.15 Million CNY	-728.645%
Dezhan Healthcare Company Limited	-2.78 Billion CNY	160.659%
Jinling Pharmaceutical Company Limited	-1.42 Billion CNY	218.725%
Jiuzhitang Co., Ltd.	-486.85 Million CNY	447.473%
Huapont Life Sciences Co., Ltd.	4.84 Billion CNY	65.069%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	-758.15 Million CNY	323.132%
Shandong Wohua Pharmaceutical Co., Ltd.	-398.37 Million CNY	524.649%
Hengkang Medical Group Co., Ltd.	1.47 Billion CNY	-14.562%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	-527.44 Million CNY	420.734%
Qianjiang Yongan Pharmaceutical Co., Ltd.	-278.86 Million CNY	706.631%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	3.71 Billion CNY	54.416%
Teyi Pharmaceutical Group Co.,Ltd	-300.09 Million CNY	663.715%
Kunming Longjin Pharmaceutical Co., Ltd.	-209.75 Million CNY	906.511%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-923.24 Million CNY	283.232%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	-4.7 Billion CNY	135.992%
Anhui Huangshan Capsule Co., Ltd.	-162.29 Million CNY	1142.356%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	-999.51 Million CNY	269.25%
Zhuhai Rundu Pharmaceutical Co., Ltd.	358.96 Million CNY	-371.269%
Huaren Pharmaceutical Co., Ltd.	1.64 Billion CNY	-2.566%
Tianjin Ringpu Bio-Technology Co.,Ltd.	536.67 Million CNY	-215.217%
Shanxi Zhendong Pharmaceutical Co.,Ltd	-798.02 Million CNY	311.984%
Fuan Pharmaceutical (Group) Co., Ltd.	-98.97 Million CNY	1809.154%
Hybio Pharmaceutical Co., Ltd.	1.66 Billion CNY	-1.594%
Baotou Dongbao Bio-Tech Co.,Ltd	-279.4 Million CNY	705.453%
Hunan Er-Kang Pharmaceutical Co., Ltd	-381.73 Million CNY	543.158%
Changjiang Pharmaceutical Group Co., Ltd.	822.28 Million CNY	-105.73%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	176.92 Million CNY	-856.17%
Fujian Cosunter Pharmaceutical Co., Ltd.	256.43 Million CNY	-559.69%
Beijing Science Sun Pharmaceutical Co., Ltd.	-120.16 Million CNY	1507.81%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	-543.94 Million CNY	411.003%
Hainan Poly Pharm. Co., Ltd	2.02 Billion CNY	16.441%
Jiangxi Synergy Pharmaceutical Co., Ltd.	256.2 Million CNY	-560.284%
Wuhan Hiteck Biological Pharma Co.,Ltd	-444.26 Million CNY	480.787%
Shandong Xinhua Pharmaceutical Company Limited	955.82 Million CNY	-76.988%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	1.37 Billion CNY	-23.25%
PharmaBlock Sciences (Nanjing), Inc.	1.31 Billion CNY	-28.279%
Jinghua Pharmaceutical Group Co., Ltd.	-885.75 Million CNY	290.988%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-367.05 Million CNY	560.883%
Betta Pharmaceuticals Co., Ltd.	1.67 Billion CNY	-0.947%
Tibet AIM Pharm. Inc.	-374.84 Million CNY	551.303%
Shenzhen Kangtai Biological Products Co., Ltd.	1.35 Billion CNY	-25.22%
Shandong Shanda Wit Science and Technology Co., Ltd.	-2.04 Billion CNY	182.602%
Pacific Shuanglin Bio-pharmacy Co., LTD	-933.33 Million CNY	281.253%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	-271.99 Million CNY	721.966%
Xiamen Kingdomway Group Company	288.99 Million CNY	-485.362%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	261.8 Million CNY	-546.157%
Walvax Biotechnology Co., Ltd.	-3.52 Billion CNY	147.985%
Sunflower Pharmaceutical Group Co.,Ltd	-2.25 Billion CNY	174.955%
Harbin Gloria Pharmaceuticals Co., Ltd	-36.41 Million CNY	4745.545%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	-2.41 Billion CNY	170.161%
Hunan Hansen Pharmaceutical Co., Ltd.	58.32 Million CNY	-2800.578%
Changzhou Qianhong Biopharma CO.,LTD	-520.12 Million CNY	425.247%
Shenzhen Weiguang Biological Products Co., Ltd.	273.09 Million CNY	-519.442%
Honz Pharmaceutical Co., Ltd.	357.24 Million CNY	-373.543%
Northeast Pharmaceutical Group Co., Ltd.	1.26 Billion CNY	-34.227%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.53 Billion CNY	-10.532%
Guizhou Xinbang Pharmaceutical Co., Ltd.	277.92 Million CNY	-508.695%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	-1.92 Billion CNY	187.837%
Zhejiang Yatai Pharmaceutical Co., Ltd.	-30.93 Million CNY	5567.936%
Zhejiang NHU Company Ltd.	5.08 Billion CNY	66.723%
ApicHope Pharmaceutical Co., Ltd	379.9 Million CNY	-345.293%
Shanghai Kaibao Pharmaceutical CO.,Ltd	-597.65 Million CNY	383.052%
Beijing SL Pharmaceutical Co., Ltd.	-646.23 Million CNY	361.775%
Yunnan Baiyao Group Co.,Ltd	-10.37 Billion CNY	116.312%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	-144.4 Million CNY	1271.491%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	123.63 Million CNY	-1268.289%
Guangdong Lifestrong Pharmacy Co., Ltd.	-117.15 Million CNY	1543.964%
Huadong Medicine Co., Ltd	-919.23 Million CNY	284.033%
Jiangsu Nhwa Pharmaceutical Co., LTD	-1.98 Billion CNY	185.164%
Harbin Medisan Pharmaceutical Co., Ltd.	-272.78 Million CNY	720.152%
LanZhou Foci Pharmaceutical Co.,Ltd.	-380 Million CNY	545.17%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	-40.24 Million CNY	4303.749%
Beijing Beilu Pharmaceutical Co., Ltd	42.89 Million CNY	-3844.168%
Nanjing Hicin Pharmaceutical Co., Ltd.	252.61 Million CNY	-569.663%
Renhe Pharmacy Co., Ltd.	-2.59 Billion CNY	165.164%
Chongqing Pharscin Pharmaceutical Co., Ltd.	-437.28 Million CNY	486.863%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	-1.21 Billion CNY	239.292%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	827.4 Million CNY	-104.457%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	1.29 Billion CNY	-30.567%

Global Stocks Search

Jinhe Biotechnology CO., LTD. (002688.SZ)

Net Debt Summary of Jinhe Biotechnology CO., LTD.

Annual Net Debt Chart of Jinhe Biotechnology CO., LTD. (2023 - 2008)

Historical Annual Net Debt of Jinhe Biotechnology CO., LTD. (2023 - 2008)

Peer Net Debt Comparison of Jinhe Biotechnology CO., LTD.